Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.

HIV clinical trials - 1 Jan 2000

Casado Jose L, Moreno Ana, Martí-Belda Paloma, Sabido Raquel, Pinheiro Sofía, Bermudez Elena, Antela Antonio, Dronda Fernando, Perez-Elías María J, Moreno Santiago

Abstract excerpt

PURPOSE: To explore the possibility of overcoming resistance to protease inhibitors (PIs) and to determine the resistance cutoff values that continue to predict treatment failure with a dual PI regimen. METHOD: We performed a prospective study of 53 patients who had failed in several PIs and who were included in a ritonavir (RTV) plus indinavir (IDV) salvage regimen. Median HIV RNA level decrease was evaluated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to Indinavir

Share to Ritonavir

Share to Salvage Therapy

Source

Identifiers

PMID: 12577193
DOI: 10.1310/KDUH-FJC3-NGYH-XPWY

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.PMID 12577193Read ↗

Protease inhibitor resistance update: where are we now?Semantic proximity Read ↗

Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures.Semantic proximity Read ↗

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.Semantic proximity Read ↗

Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients.Semantic proximity Read ↗

High prevalence of PI resistance in patients failing second-line ART in Vietnam.Semantic proximity Read ↗

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.Semantic proximity Read ↗

Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.Semantic proximity Read ↗

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.Semantic proximity Read ↗

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies.Semantic proximity Read ↗

Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.